By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Anaeropharma Science 

4th Fl., Yaesu KH Building
19-8, Nihonbashi Kabuto-cho
Chuo-ku  Tokyo   103-0026  Japan
Phone: n/a Fax: n/a


SEARCH JOBS

Anaeropharma is a biopharmaceutical company engaged in research and development of drug candidates that target hypoxic microenvironments of tumors by using recombinant "Bifidobacterium". This approach offers broad potential to be more effective to solid tumors and less toxic to healthy tissues than conventional anti-cancer drugs. APS001F, a recombinant "Bifidobacterium" to express Cytosine Deaminase which converts a prodrug, 5-FC, to an anti-cancer drug, 5-FU, is its leading development product which is under a clinical trial in the U.S., and additional programs in the immune oncology area such as immune checkpoint blockers and other immune-related molecules expressing recombinant "Bifidobacteria" are under active development.

YEAR FOUNDED:

2004

LEADERSHIP:

CEO: Tetsuya Mishima

JOBS:

Please click here for Anaeropharma Science.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@anaeropharm.co-jp
Ownership: Private

Web Site: Anaeropharma Science
Employees:
Symbol: 
 









Company News
//-->